pregulation of TCF21 inhibits migration of adrenoc... - BV FAPESP
Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

pregulation of TCF21 inhibits migration of adrenocortical carcinoma cell

Texto completo
Autor(es):
Kremer, Jean Lucas [1] ; Auricino, Thais Barabba [1] ; dos Santos Passaia, Barbara [1] ; Lotfi, Claudimara Ferini Pacicco [1]
Número total de Autores: 4
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: HORMONES & CANCER; v. 12, n. 1 JUL 23 2021.
Citações Web of Science: 0
Resumo

Background Adrenocortical carcinomas (ACC) are rare and aggressive cancer. Our previous study has revealed that the transcription factor 21, TCF21, is downregulated in ACC and regulates steroidogenic factor 1 (SF-1) binding to the SF-1 E-box promoter. In addition, it could be found that TCF21 is a predictor of overall survival (OS) in adult carcinomas. Methods In this study, it was investigated the correlation between TCF21 expression and the promoter methylation status in adrenocortical tumor cells, carcinomas and adenoma. The biological function and potential molecular mechanism of TCF21 restoration in migration and invasion of ACC cells was examined. Results We could be demonstrated a negative correlation between the level of TCF21 expression and methylation of its promoter in adenoma and carcinoma cells indicating the epigenetic control of TCF21 expression. It was also demonstrated that the expression of TCF21 inhibits migration and invasion in the ACC cell line, H295R cells, using plasmid transfection to express TCF21. Furthermore, it could be investigated the TCF21 function as tumor suppressor probably through Kisspeptin 1 (KISS-1) expression and epithelial-mesenchymal transition (EMT) reversion, as well as the modulation of several metalloproteinases in ACC cells. Conclusions Our results suggest that enhancement of TCF21 expression levels may be a potential strategy to revert invasive abilities in adrenocortical carcinomas. (AU)

Processo FAPESP: 16/17285-6 - Análise da regulação epigenética do fator de transcrição POD1/TCF21 em culturas de células de tumores adrenocorticais, e seu papel na migração e invasão celular.
Beneficiário:Jean Lucas Kremer
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 18/19035-2 - Estudo morfológico, funcional e molecular da diferenciação celular do córtex adrenal: o papel do gene SOCS3
Beneficiário:Claudimara Ferini Pacicco Lotfi
Modalidade de apoio: Auxílio à Pesquisa - Regular